Veterinary SME experience Presented by: Dr Karen QUIGLEY European - - PowerPoint PPT Presentation

veterinary sme experience
SMART_READER_LITE
LIVE PREVIEW

Veterinary SME experience Presented by: Dr Karen QUIGLEY European - - PowerPoint PPT Presentation

Veterinary SME experience Presented by: Dr Karen QUIGLEY European Medicines Agency An agency of the European Union SME-Veterinary Growth area on veterinary side 63 companies registered vet interest Same incentives as human side SME


slide-1
SLIDE 1

An agency of the European Union

Presented by: Dr Karen QUIGLEY European Medicines Agency

Veterinary SME experience

slide-2
SLIDE 2

2

Growth area on veterinary side 63 companies registered vet interest Same incentives as human side – SME office Pre-submission meetings -teleconference Scientific advice MUMS / limited markets

SME-Veterinary

slide-3
SLIDE 3

3

Scientific advice

  • Submit request 2 weeks prior to monthly SAWP-

V meeting

  • Independent of route of authorisation
  • Co-ordinator appointed+ experts+ other WPs
  • Timetable 30 or 60 days
  • Draft report discussed SAWP-V
  • Adopted by CVMP- not binding
slide-4
SLIDE 4

4

Procedure

  • Fees depend on area advice
  • SME applicants 90% fee waiver – inform SME
  • ffice prior to request
  • Minor use minor species (MUMS) request - if

benefit from financial incentives = free

  • MUMS dossier requirements for authorisation
slide-5
SLIDE 5

5

2010 Figures - SA

  • 1

1 3 5 7 9 11 13 15 17 19 21 Pharm SME Vaccines Other MUMS

slide-6
SLIDE 6

6

Areas of Advice in 2010

Quality Safety Clinical MRL

slide-7
SLIDE 7

7

Parallel Advice FDA

Confidentiality Agreement FDA Applicant to address request to both Agencies Agreement principles since 2004 pilot Applicant initiative- exceptionally Agency initiative

slide-8
SLIDE 8

8

Minor Use Minor Species (MUMS)

To stimulate applications for minor species and minor uses in major species Policy published on website Started September 2009 43 requests for classification to date and 19 of those from SMEs MUMs data requirements where applicable Financial incentives-some products

slide-9
SLIDE 9

9

Centralised procedure

In 2010 four applications validated (~ 20% total) Biosimilar, oncology, 2 generics of centrally authorised product Include in EPAR if an SME E-submission Translation product information

slide-10
SLIDE 10

10

Conclusions

Apply SME office registration Guidance on web for SA-MUMS-authorisation Increased requests recent years from SMEs Queries vet.applications@ema.europa.eu